Pronutria Biosciences is fundamentally transforming health by unlocking the potential of homeostatic biology. Homeostasis is a critical component of healthy physiology that is disrupted in a range of serious diseases. Pronutria Biosciences has developed a proprietary library with over one billion proteins along with the tools necessary to select, validate and express individual proteins with precise amino acid and biophysical profiles. Using our first-in-class, proprietary platform, we identify and produce oral biologics that liberate precise, temporally controlled amino acid ratios to restore imbalances in amino acids that are at the heart of important diseases including cancers, rare genetic diseases and disorders affecting the musculoskeletal, gastrointestinal, neurological, metabolic and autoimmune systems. These powerful oral biologics elicit specific, beneficial physiological effects that restore cellular homeostasis and subsequently health.
Noubar Afeyan is Chairman and David Berry is on the Board of Directors.